Botté M C, Lerrant Y, Lozach A, Bérault A, Counis R, Kottler M L
Endocrinologie Cellulaire et Moléculaire de la Reproduction, Université P&M Curie, CNRS ESA 7080, 75005 Paris, France.
J Endocrinol. 1999 Sep;162(3):409-15. doi: 10.1677/joe.0.1620409.
The demonstration of an inhibitory effect of gonadotropin-releasing hormone (GnRH) agonists upon steroidogenesis in hypophysectomized rats and the presence of mRNA coding for GnRH and GnRH receptors (GnRH-R) in rat gonads suggests that GnRH can act locally in the gonads. To assess this hypothesis, we investigated the effects of GnRH analogs, gonadotropins and testosterone on the levels of both GnRH and GnRH-R mRNA in the rat testis. Using dot blot hybridization, we measured the mRNA levels 2 to 120 h after the administration of the GnRH agonist, triptorelin. We observed an acute reduction of both GnRH and GnRH-R mRNAs 24 h after the injection (about 38% of control). However, the kinetics for testis GnRH-R mRNA were different from those previously found for pituitary GnRH-R mRNA under the same conditions. Initially, the concentrations of serum LH and FSH peaked, then declined, probably due to the desensitization of the gonadotrope cells. In contrast, the GnRH antagonist, antarelix, after 8 h induced a 2.5-fold increase in GnRH-R mRNA, but not in GnRH mRNA, while gonadotropins levels were reduced. Human recombinant FSH had no significant effect on either GnRH or GnRH-R mRNA levels. Inversely, GnRH-R mRNA levels markedly decreased by 21% of that of control 24 h after hCG injection. Finally, 24 h after testosterone injection, a significant increase in GnRH-R mRNA levels (2.3 fold vs control) was found, but a reduction in the concentration of serum LH, probably by negative feedback on the pituitary, was observed. In contrast, GnRH mRNA levels were not significantly altered following testosterone treatment. Since LH receptors, GnRH-R and testosterone synthesis are colocalized in Leydig cells, our data suggest that LH could inhibit the GnRH-R gene expression or decrease the GnRH-R mRNA stability in the testis. However, this does not exclude the possibility that GnRH analogs could also affect the GnRH-R mRNA levels via direct binding to testicular GnRH-R. In contrast, the regulation of GnRH mRNA levels appeared to be independent of gonadotropins. Taken together, our results suggest a regulation of GnRH and GnRH-R mRNA specific for the testis.
促性腺激素释放激素(GnRH)激动剂对垂体切除大鼠的类固醇生成具有抑制作用,且大鼠性腺中存在编码GnRH和GnRH受体(GnRH-R)的mRNA,这表明GnRH可在性腺中发挥局部作用。为评估这一假说,我们研究了GnRH类似物、促性腺激素和睾酮对大鼠睾丸中GnRH和GnRH-R mRNA水平的影响。使用斑点印迹杂交法,我们在给予GnRH激动剂曲普瑞林后2至120小时测量mRNA水平。我们观察到注射后24小时GnRH和GnRH-R mRNA均急剧减少(约为对照的38%)。然而,睾丸GnRH-R mRNA的动力学与之前在相同条件下垂体GnRH-R mRNA的动力学不同。最初,血清促黄体生成素(LH)和促卵泡生成素(FSH)浓度达到峰值,然后下降,这可能是由于促性腺激素细胞脱敏所致。相反,GnRH拮抗剂安他瑞克在8小时后使GnRH-R mRNA增加2.5倍,但对GnRH mRNA无影响,而促性腺激素水平降低。重组人FSH对GnRH或GnRH-R mRNA水平均无显著影响。相反,注射人绒毛膜促性腺激素(hCG)24小时后,GnRH-R mRNA水平显著下降至对照水平的21%。最后,注射睾酮24小时后,发现GnRH-R mRNA水平显著升高(是对照的2.3倍),但血清LH浓度降低,这可能是由于对垂体的负反馈作用。相比之下,睾酮处理后GnRH mRNA水平无显著变化。由于LH受体、GnRH-R和睾酮合成共定位于睾丸间质细胞,我们的数据表明LH可能抑制睾丸中GnRH-R基因表达或降低GnRH-R mRNA稳定性。然而,这并不排除GnRH类似物也可能通过直接结合睾丸GnRH-R影响GnRH-R mRNA水平的可能性。相反,GnRH mRNA水平的调节似乎与促性腺激素无关。综上所述,我们的结果表明睾丸中GnRH和GnRH-R mRNA存在特异性调节。